LivaNova (LIVN) Shareholder's Equity (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.94% |
| Dec 31, 2025 | 3.69% |
| Sep 30, 2025 | 3.06% |
| Jun 30, 2025 | 8.56% |
| Mar 31, 2025 | -21.66% |
| Dec 31, 2024 | 0.78% |
| Sep 30, 2024 | 5.43% |
| Jun 30, 2024 | 1.72% |
| Mar 31, 2024 | -4.39% |
| Dec 31, 2023 | 4.26% |
| Sep 30, 2023 | -1.22% |
| Jun 30, 2023 | 1.08% |
| Mar 31, 2023 | 1.63% |
| Dec 31, 2022 | 5.29% |
| Sep 30, 2022 | -10.53% |
| Jun 30, 2022 | -0.76% |
| Mar 31, 2022 | -0.22% |
| Dec 31, 2021 | -0.37% |
| Sep 30, 2021 | 26.33% |
| Jun 30, 2021 | -2.51% |
| Mar 31, 2021 | -4.88% |
| Dec 31, 2020 | -17.88% |
| Sep 30, 2020 | 1.32% |
| Jun 30, 2020 | -4.27% |
| Mar 31, 2020 | 1.07% |
| Dec 31, 2019 | -7.85% |
| Sep 30, 2019 | 0.81% |
| Jun 30, 2019 | -0.23% |
| Mar 31, 2019 | -0.91% |
| Dec 31, 2018 | -15.94% |
| Sep 30, 2018 | 0.11% |
| Jun 30, 2018 | -1.98% |
| Mar 31, 2018 | 0.20% |
| Dec 31, 2017 | 4,618.90% |
| Sep 30, 2017 | 43,323.60% |
| Jun 30, 2017 | 99.84% |
| Mar 31, 2017 | -103.32% |
| Dec 31, 2016 | 60,564.36% |
| Sep 30, 2016 | 88.66% |
| Jun 30, 2016 | -276.49% |
| Mar 31, 2016 | -100.37% |